Tech Company Financing Transactions

Areteia Therapeutics Funding Round

On 7/12/2022, Areteia Therapeutics raised $350 million in Series A funding from Bain Capital Life Sciences and private investors.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series A

Bain Capital Life Sciences (Lead Investor) (Adam Koppel)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Mailing Address
50 Mountaintop Rd.
Bernardsville, NJ 07924
Email Address
Our global development team brings together experts from Knopp Biosciences, which previously developed dexpramipexole, and Population Health Partners, whose employees and executives led eight drug approvals involving 21 clinical trials and 91,000 patients worldwide in their earlier work at The Medicines Company.
Areteia Therapeutics LinkedIn Company Profile
Social Media
Areteia Therapeutics Company Twitter Account
Company News
Areteia Therapeutics News
Areteia Therapeutics on Facebook
Areteia Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Jorge Bartolome
  Jorge Bartolome LinkedIn Profile  Jorge Bartolome Twitter Account  Jorge Bartolome News  Jorge Bartolome on Facebook
Chief Financial Officer
Chris Visioli
  Chris Visioli LinkedIn Profile  Chris Visioli Twitter Account  Chris Visioli News  Chris Visioli on Facebook
Chief Scientific Officer
Calman Prussin
  Calman Prussin LinkedIn Profile  Calman Prussin Twitter Account  Calman Prussin News  Calman Prussin on Facebook
VP - Bus. Development
Mark Kreston
  Mark Kreston LinkedIn Profile  Mark Kreston Twitter Account  Mark Kreston News  Mark Kreston on Facebook
VP - Bus. Development
Peter Wijngaard
  Peter Wijngaard LinkedIn Profile  Peter Wijngaard Twitter Account  Peter Wijngaard News  Peter Wijngaard on Facebook
VP - General Counsel
Chris Cox
  Chris Cox LinkedIn Profile  Chris Cox Twitter Account  Chris Cox News  Chris Cox on Facebook
VP - Human Resources
Richard Fires
  Richard Fires LinkedIn Profile  Richard Fires Twitter Account  Richard Fires News  Richard Fires on Facebook
VP - Regulatory Affairs
Lex Kay
  Lex Kay LinkedIn Profile  Lex Kay Twitter Account  Lex Kay News  Lex Kay on Facebook



Browse more venture capital transactions:

Prev: 7/12/2022: SERG Technologies venture capital transaction
Next: 7/12/2022: Wheelocity venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary